fda compounding semaglutide crackdown 2025 news September 2, 2025: U.S. restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines The GLP-1 drug shortage is

Watch for these warning signs: Persistent body image concerns affecting daily activities Anxiety about medication effectiveness or access Difficulty adapting to physical changes Social withdrawal or isolation Increased stress about weight management Persistent negative thoughts about self-worth Healthcare experts recommend seeking professional help if these symptoms persist for more than two weeks or begin interfering with daily activities

They may be selling unauthorized or counterfeit medications

What You'll Discover: What retatrutide is and how it works in the body

GLP-1 (glucagon-like peptide-1) receptor agonists are a type of injectable medication originally developed to manage type 2 diabetes